
This real-time PCR assay (RUO) enables quantitative detection of residual E.coli host genomic DNA in extracted nucleic acid samples from biopharmaceutical products.
Feature | Specification |
---|---|
Analytical Sensitivity | > 0.03 pg/rxn |
This real-time PCR assay (RUO) enables quantitative detection of residual E.coli host genomic DNA in extracted nucleic acid samples from biopharmaceutical products.
The HostDetect™ E.coli PCR DNA Quant Kit is specific for DNA from E.coli genome. The reagents utilize sequence-specific primers and TaqMan® probe to amplify the 16S ribosomal RNA gene of E.coli genomic DNA for residual host genomic identification. A primer/probe set to detect Internal Control (IC), is also included for monitoring entire process from extraction to real-time PCR. The reagents also use a dUTP/UNG carryover prevention system to avoid contamination of PCR products. For more information, contact: BioprocessQC@revvity.com
Key Highlights:
HostDetect™ E.coli PCR DNA Quant Kit Workflow
The probes for the E.coli genomic DNA and Internal Control detection are labeled with FAM and HEX/VIC fluorescent dyes, respectively, to generate target-specific signal. ROX is used for Passive Reference. Any Real-time qPCR Instruments with FAM™ and VIC®/HEX™ channels can be used with this assay.
HostDetect™ E.coli PCR DNA Quant Kit Quantification Range**
**: ATCC or USP reference standards for residual DNAs are not included in the kit. Customer must order these separately from ATCC or USP web sites.
Features:
Quantification Range | 0.3 ng to 0.03 pg/rxn |
---|---|
Linearity | R2 ≥ 0.99, Eff%= 100±20% |
Sensitivity | ≥ 0.03 pg/rxn |
Precision | CV < 5% at 0.03 pg/rxn |
Shipping Conditions | Shipped on Dry ice |
Storage Conditions | -25 to -15 °C |
Analytical Sensitivity |
> 0.03 pg/rxn
|
---|---|
Shipping Conditions |
Shipped in Dry Ice
|
Storage Conditions |
-25C to -15C
|
Unit Size |
192 rxns
|
Are you looking for resources, click on the resource type to explore further.
"Residual HEK293 DNA is a critical impurity that must be minimized when generating recombinant AAV (rAAV) therapeutic products, as...
Loading...
We are here to answer your questions.